Provided by Tiger Trade Technology Pte. Ltd.

Cabot

83.88
-1.3100-1.54%
Post-market: 83.880.00000.00%19:30 EDT
Volume:281.21K
Turnover:23.67M
Market Cap:4.33B
PE:23.58
High:85.50
Open:85.45
Low:83.47
Close:85.19
52wk High:94.53
52wk Low:58.33
Shares:51.62M
Float Shares:50.93M
Volume Ratio:0.73
T/O Rate:0.55%
Dividend:1.82
Dividend Rate:2.17%
EPS(TTM):3.56
EPS(LYR):6.02
ROE:13.35%
ROA:8.90%
PB:2.70
PE(LYR):13.93

Loading ...

There's Big Money to be Made in European Real Estate

Dow Jones
·
Jun 26

Cabot Corp is Maintained at Neutral by Mizuho

Dow Jones
·
Jun 26

Cabot Corp : Mizuho Raises Target Price to $90 from $80

THOMSON REUTERS
·
Jun 25

U.S. Research Roundup-caseys General Stores, Micron Technology, SAP

Reuters
·
Jun 25

Cabot launches 2026 sustainability report

Reuters
·
Jun 23

Cabot Corporation Releases 2026 Sustainability Report Demonstrating Continued Progress on Sustainability Priorities

GlobeNewswire
·
Jun 23

Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating

Simply Wall St.
·
Jun 22

3 US Dividend Stocks With Balance Sheet Strength And Payout Growth

Simply Wall St.
·
Jun 20

Is Cabot’s (CBT) Elite ESG Status Quietly Reshaping Its Long-Term Competitive Position?

Simply Wall St.
·
Jun 19

Cabot earns sixth straight EcoVadis platinum ESG rating

Reuters
·
Jun 18

Cabot Corporation Earns EcoVadis Platinum Rating for Sixth Consecutive Year

GlobeNewswire
·
Jun 18

Cabot Corp Initiated at Buy by Truist Securities

Dow Jones
·
Jun 09

U.S. RESEARCH ROUNDUP- Adobe, Allstate, Teleflex

Reuters
·
Jun 08

Cloudbreak Pharma Announces Final Patient Visit for 12-Month Efficacy Endpoint in Phase 3 Study of CBT-001 as a Potential Treatment for Pterygium

GlobeNewswire
·
Jun 05

Cloudbreak Reaches Key Phase 3 Milestone for First-in-Class Pterygium Drug CBT-001

TIPRANKS
·
Jun 04

Cloudbreak-B Completes Final 12-Month Endpoint Visit for CBT-001

Stock News
·
Jun 04

Does Cabot’s Cost Cuts and Dividend Hike Reshape the Bull Case for CBT?

Simply Wall St.
·
Jun 02

Cabot : Deutsche Bank Raises Target Price to $85 From $80

THOMSON REUTERS
·
May 26

U.S. RESEARCH ROUNDUP-Apollo, Phillips 66, Valero Energy

Reuters
·
May 26

CLOUDBREAK-B (02592) Submits Investigational New Drug Application for CBT-358

Stock News
·
May 22